Header cover image

Canadian (TSX) Drug Retail Industry Analysis

UpdatedJan 30, 2025
DataAggregated Company Financials
Companies2
  • 7D-2.5%
  • 3M-3.6%
  • 1Y46.8%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has risen 2.2%, driven by gains from every company within the industry. In the last 12 months, the industry was up 42%. Earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the Canadian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Jan 2025CA$199.2mCA$367.0m-CA$7,944,338.00n/a-25.1x0.5x
Sat, 28 Dec 2024CA$182.7mCA$367.0m-CA$7,944,338.00n/a-23x0.5x
Mon, 25 Nov 2024CA$180.0mCA$365.9m-CA$7,071,267.00n/a-25.5x0.5x
Wed, 23 Oct 2024CA$201.6mCA$366.8m-CA$8,148,267.00n/a-24.7x0.5x
Fri, 20 Sep 2024CA$192.5mCA$366.8m-CA$8,148,267.00n/a-23.6x0.5x
Sun, 18 Aug 2024CA$175.9mCA$366.6m-CA$7,621,633.00n/a-23.1x0.5x
Tue, 16 Jul 2024CA$131.1mCA$369.1m-CA$3,773,000.00n/a-34.7x0.4x
Thu, 13 Jun 2024CA$135.3mCA$369.1m-CA$3,773,000.00n/a-35.9x0.4x
Sat, 11 May 2024CA$122.7mCA$370.7m-CA$5,405,000.00n/a-22.7x0.3x
Mon, 08 Apr 2024CA$124.0mCA$370.7m-CA$5,405,000.00n/a-22.9x0.3x
Wed, 06 Mar 2024CA$924.0mCA$1.2b-CA$39,086,000.00n/a-23.6x0.7x
Fri, 02 Feb 2024CA$909.9mCA$1.2b-CA$43,234,000.00n/a-21x0.7x
Sun, 31 Dec 2023CA$840.0mCA$1.2b-CA$43,234,000.00n/a-19.4x0.7x
Tue, 28 Nov 2023CA$855.6mCA$1.2b-CA$32,998,000.00n/a-25.9x0.7x
Thu, 26 Oct 2023CA$842.2mCA$1.2b-CA$43,579,000.00n/a-19.3x0.7x
Sat, 23 Sep 2023CA$730.4mCA$1.2b-CA$33,343,000.00n/a-21.9x0.6x
Mon, 21 Aug 2023CA$839.2mCA$1.2b-CA$33,343,000.00n/a-25.2x0.7x
Wed, 19 Jul 2023CA$833.6mCA$1.1b-CA$49,239,000.00n/a-16.9x0.7x
Fri, 16 Jun 2023CA$957.2mCA$1.1b-CA$54,206,633.00n/a-17.7x0.8x
Sun, 14 May 2023CA$1.0bCA$1.1b-CA$40,586,633.00n/a-25.3x1x
Tue, 11 Apr 2023CA$1.1bCA$1.1b-CA$41,199,633.00n/a-27.9x1.1x
Thu, 09 Mar 2023CA$1.2bCA$1.1b-CA$41,345,953.00n/a-29.3x1.1x
Sat, 04 Feb 2023CA$1.1bCA$937.3m-CA$33,260,953.00149.9x-32x1.1x
Mon, 02 Jan 2023CA$1.2bCA$849.1m-CA$36,693,953.00373.5x-31.8x1.4x
Wed, 30 Nov 2022CA$1.2bCA$849.1m-CA$36,693,953.00382.3x-32.5x1.4x
Fri, 28 Oct 2022CA$1.2bCA$821.8m-CA$42,878,845.00366.3x-27.1x1.4x
Sun, 25 Sep 2022CA$1.0bCA$821.8m-CA$42,878,845.00306.9x-23.6x1.2x
Tue, 23 Aug 2022CA$1.1bCA$821.8m-CA$42,878,845.00322.6x-25x1.3x
Thu, 21 Jul 2022CA$1.2bCA$744.3m-CA$104,337,767.00n/a-11.5x1.6x
Sat, 18 Jun 2022CA$940.1mCA$715.2m-CA$82,721,767.00n/a-11.4x1.3x
Mon, 16 May 2022CA$1.1bCA$709.4m-CA$71,366,000.00n/a-15.3x1.5x
Wed, 13 Apr 2022CA$1.2bCA$661.1m-CA$74,470,000.00n/a-15.6x1.8x
Fri, 11 Mar 2022CA$1.3bCA$630.4m-CA$72,466,892.0071.9x-18.2x2.1x
Sun, 06 Feb 2022CA$1.4bCA$600.6m-CA$184,004,892.0097x-7.4x2.3x
Price to Earnings Ratio

-7.4x


Total Market Cap: CA$1.4bTotal Earnings: -CA$184,004,892.00Total Revenue: CA$600.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Drug Retail Industry Price to Earnings3Y Average -23.8x202320242025
Current Industry PE
    There are only 2 companies in the Canadian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 14% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Canadian Drug Retail compare with similar industries?

CA Market0.048%
Consumer Staples0.41%
Food and Staples Retail0.29%
Drug Retail-2.55%
Big Box Super Stores28.57%
Food Distributors0.43%
Food Retail0.29%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRRX CareRxCA$2.261.8%
+CA$2.5m
46.8%PS0.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CRRX

CA$2.26

CareRx

7D

1.8%

1Y

46.8%

PCRX

CA$0.49

PharmaCorp Rx

7D

-11.6%

1Y

n/a